α干扰素在血液系统恶性肿瘤中的应用

alpha-Interferon in hematological malignancies.

作者信息

Giles F J, Ozer H

机构信息

Division of Medical Oncology, School of Medicine, University of North Carolina, Chapel Hill 27599-7305.

出版信息

Curr Opin Biotechnol. 1991 Dec;2(6):847-50. doi: 10.1016/s0958-1669(05)80119-3.

DOI:10.1016/s0958-1669(05)80119-3

PMID:1367959

Abstract

Recent studies have generated data demonstrating significant clinical activity of alpha-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkin's lymphomas, multiple myelomatosis and hairy cell leukaemia.

摘要

最近的研究已产生数据，证明α-干扰素疗法在六种血液系统恶性肿瘤（慢性粒细胞白血病、原发性血小板增多症、真性红细胞增多症、非霍奇金淋巴瘤、多发性骨髓瘤和毛细胞白血病）中的每一种都具有显著的临床活性。